News from the FDA/CDC
News from the FDA/CDC
FDA moves to expand coronavirus testing capacity; CDC clarifies testing criteria
Close to a million tests will be available by week’s end, predicted HHS Secretary Alex Azar
News from the FDA/CDC
FDA approves weekly contraceptive patch Twirla
The levonorgestrel and ethinyl estradiol contraceptive is contraindicated in obese women.
News from the FDA/CDC
Lorcaserin withdrawn from U.S. market due to cancer risk
The Food and Drug Administration advised health care professionals to stop prescribing and dispensing lorcaserin and to contact patients who are...
News from the FDA/CDC
Washington state patient is first U.S. case of novel coronavirus
News
FDA panel okays teprotumumab for thyroid eye disease
Until now, the disease that has not really been treatable, with current treatment aimed at relief of symptoms.
News from the FDA/CDC
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
Feature
President to nominate oncologist to lead FDA
President Trump has indicated his intent to nominate Stephen Hahn, MD, as FDA Commissioner.
News from the FDA/CDC
Twin births down among women 30 and older
Race and ethnicity also played a role in the decline in twin birthrates since 2014.
News from the FDA/CDC
FDA approves oral semaglutide for HbA1c management in type 2 diabetes
It is the first glucagonlike peptide–1 receptor agonist treatment in pill form for this condition.
News from the FDA/CDC
Prescription drug use varies between U.S. and Canada
Patterns also differ by age, but lipid lowering is strong in both countries.
News
HHS proposes pathways for drug importation
Officials at the U.S. Department of Health and Human Services have announced a new plan that they say would lay the foundation for safe...